| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis.
|
Biogerontology
|
2001
|
3.00
|
|
2
|
Isolation and characterization of osteoblast precursor cells from human bone marrow.
|
J Bone Miner Res
|
1996
|
2.16
|
|
3
|
Human mesenchymal stem cells: from basic biology to clinical applications.
|
Gene Ther
|
2007
|
2.00
|
|
4
|
Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures.
|
Calcif Tissue Int
|
2002
|
1.53
|
|
5
|
Bone regeneration and stem cells.
|
J Cell Mol Med
|
2011
|
1.41
|
|
6
|
Number and proliferative capacity of osteogenic stem cells are maintained during aging and in patients with osteoporosis.
|
J Bone Miner Res
|
2001
|
1.39
|
|
7
|
Troglitazone treatment increases bone marrow adipose tissue volume but does not affect trabecular bone volume in mice.
|
Calcif Tissue Int
|
2001
|
1.32
|
|
8
|
Demonstration of the presence of independent pre-osteoblastic and pre-adipocytic cell populations in bone marrow-derived mesenchymal stem cells.
|
Bone
|
2008
|
1.30
|
|
9
|
Age- and sex-related changes in iliac cortical bone mass and remodeling.
|
Bone
|
1994
|
1.19
|
|
10
|
Tissue distribution and engraftment of human mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene.
|
Biochem Biophys Res Commun
|
2005
|
1.10
|
|
11
|
Effect of hormone replacement therapy on bone quality in early postmenopausal women.
|
J Bone Miner Res
|
2003
|
1.05
|
|
12
|
MAPKs are essential upstream signaling pathways in proteolytic cartilage degradation--divergence in pathways leading to aggrecanase and MMP-mediated articular cartilage degradation.
|
Osteoarthritis Cartilage
|
2009
|
1.02
|
|
13
|
The human umbilical cord blood: a potential source for osteoblast progenitor cells.
|
Calcif Tissue Int
|
2002
|
1.01
|
|
14
|
Ultrastructural investigations of bone resorptive cells in two types of autosomal dominant osteopetrosis.
|
Bone
|
1994
|
1.00
|
|
15
|
Pegvisomant-induced serum insulin-like growth factor-I normalization in patients with acromegaly returns elevated markers of bone turnover to normal.
|
J Clin Endocrinol Metab
|
2003
|
0.95
|
|
16
|
The effects of IGF-I and IGF-II on proliferation and differentiation of human osteoblasts and interactions with growth hormone.
|
Eur J Clin Invest
|
1998
|
0.94
|
|
17
|
Long-term oral pamidronate treatment inhibits osteoclastic bone resorption and bone turnover without affecting osteoblastic function in multiple myeloma.
|
Eur J Haematol
|
1998
|
0.93
|
|
18
|
The von Kossa reaction for calcium deposits: silver lactate staining increases sensitivity and reduces background.
|
Histochem J
|
1993
|
0.92
|
|
19
|
Transforming growth factor-beta1 stimulates the production of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in human bone marrow stromal osteoblast progenitors.
|
J Endocrinol
|
2001
|
0.89
|
|
20
|
Cloning and identification of genes that associate with mammalian replicative senescence.
|
Exp Cell Res
|
1998
|
0.89
|
|
21
|
The histopathology of a human mesenchymal stem cell experimental tumor model: support for an hMSC origin for Ewing's sarcoma?
|
Histol Histopathol
|
2008
|
0.88
|
|
22
|
Biochemical markers of bone metabolism reflect osteoclastic and osteoblastic activity in multiple myeloma.
|
Eur J Haematol
|
2000
|
0.88
|
|
23
|
Telomere shortening during aging of human osteoblasts in vitro and leukocytes in vivo: lack of excessive telomere loss in osteoporotic patients.
|
Mech Ageing Dev
|
1999
|
0.87
|
|
24
|
Hormone replacement therapy prevents osteoclastic hyperactivity: A histomorphometric study in early postmenopausal women.
|
J Bone Miner Res
|
1999
|
0.86
|
|
25
|
Aged human bone marrow stromal cells maintaining bone forming capacity in vivo evaluated using an improved method of visualization.
|
Biogerontology
|
2004
|
0.86
|
|
26
|
Evaluation of microsatellite analysis in urine sediment for diagnosis of bladder cancer.
|
Cancer Res
|
2000
|
0.86
|
|
27
|
Cell shape and spreading of stromal (mesenchymal) stem cells cultured on fibronectin coated gold and hydroxyapatite surfaces.
|
Colloids Surf B Biointerfaces
|
2010
|
0.84
|
|
28
|
Short-term treatment with growth hormone stimulates osteoblastic and osteoclastic activity in osteopenic postmenopausal women: a dose response study.
|
J Bone Miner Res
|
1995
|
0.84
|
|
29
|
Changes in the insulin-like growth factor-system may contribute to in vitro age-related impaired osteoblast functions.
|
Exp Gerontol
|
2000
|
0.83
|
|
30
|
Frame-based and frameless stereotaxy in the localization of cavernous angiomas.
|
Neurosurg Rev
|
2002
|
0.83
|
|
31
|
Fetal antigen 2 (FA2) in human fetal osteoblasts, cultured osteoblasts and osteogenic osteosarcoma cells.
|
Anat Embryol (Berl)
|
1992
|
0.82
|
|
32
|
Quantification of fetal antigen 2 (FA2) in supernatants of cultured osteoblasts, normal human serum, and serum from patients with chronic renal failure.
|
Nephrol Dial Transplant
|
1992
|
0.82
|
|
33
|
Diurnal rhythm in serum osteocalcin: relation with sleep, growth hormone, and PTH(1-84).
|
Calcif Tissue Int
|
1991
|
0.81
|
|
34
|
1,25-Dihydroxyvitamin D3 stimulates the production of insulin-like growth factor-binding proteins-2, -3 and -4 in human bone marrow stromal cells.
|
Eur J Endocrinol
|
2001
|
0.81
|
|
35
|
CBFA1 and topoisomerase I mRNA levels decline during cellular aging of human trabecular osteoblasts.
|
J Gerontol A Biol Sci Med Sci
|
2000
|
0.80
|
|
36
|
Inhibition of the morning cortisol peak abolishes the expected morning decrease in serum osteocalcin in normal males: evidence of a controlling effect of serum cortisol on the circadian rhythm in serum osteocalcin.
|
J Clin Endocrinol Metab
|
1992
|
0.79
|
|
37
|
Treatment with 1,25-dihydroxyvitamin D3 reduces impairment of human osteoblast functions during cellular aging in culture.
|
J Cell Physiol
|
2001
|
0.79
|
|
38
|
Acute effect of 1,25-dihydroxyvitamin D3, prednisone, and 1,25-dihydroxyvitamin D3 plus prednisone on serum osteocalcin in normal individuals.
|
J Bone Miner Res
|
1991
|
0.78
|
|
39
|
Snorc is a novel cartilage specific small membrane proteoglycan expressed in differentiating and articular chondrocytes.
|
Osteoarthritis Cartilage
|
2011
|
0.78
|
|
40
|
Adult stem cells and cancer.
|
Cancer Res
|
2005
|
0.77
|
|
41
|
Mesenchymal stem cells in oral reconstructive surgery: a systematic review of the literature.
|
J Oral Rehabil
|
2013
|
0.77
|
|
42
|
Growth hormone, insulin-like growth factors and bone remodelling.
|
Eur J Clin Invest
|
1996
|
0.76
|
|
43
|
Aging of human trabecular osteoblasts in culture.
|
Arch Gerontol Geriatr
|
1994
|
0.75
|
|
44
|
[Syphilitic cranial lacunae].
|
Dakar Med
|
1982
|
0.75
|
|
45
|
Growth hormone and insulin-like growth factors as anabolic therapies for osteoporosis.
|
Horm Res
|
1993
|
0.75
|
|
46
|
Echocardiography of the pericardium in pregnancy.
|
Obstet Gynecol
|
1987
|
0.75
|
|
47
|
Effect of short-term treatment with recombinant human growth hormone on lipids and lipoproteins in women and men without growth hormone disturbances.
|
Metabolism
|
1995
|
0.75
|
|
48
|
Synergistic effects of 1,25-Dihydroxyvitamin D3 and TGF-beta1 on the production of insulin-like growth factor binding protein 3 in human bone marrow stromal cell cultures.
|
APMIS
|
2002
|
0.75
|
|
49
|
Mandibular kinematic changes after unilateral cross-bite with lateral shift correction.
|
J Oral Rehabil
|
2014
|
0.75
|
|
50
|
Evidence of a normal mean telomere fragment length in patients with Ullrich-Turner syndrome.
|
Eur J Hum Genet
|
2001
|
0.75
|
|
51
|
[Apoptosis: molecular aspects].
|
Nord Med
|
1997
|
0.75
|
|
52
|
European and North American Experience with HRT for the prevention of osteoporosis.
|
Bone
|
1996
|
0.75
|
|
53
|
Growth hormone (GH) and adult bone remodeling: the potential use of GH in treatment of osteoporosis.
|
J Pediatr Endocrinol
|
1993
|
0.75
|